×
Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Medical Devices Reimbursement Market Analysis

ID: MRFR/MED/10860-HCR
200 Pages
Rahul Gotadki
February 2026

Medical Devices Reimbursement Market Research Report: Size, Share, Trend Analysis By Medical Device Type (Diagnostic Devices, Surgical Devices, Therapeutic Devices), By Payer Type (Private Insurance, Public Insurance, Out of Pocket), By Reimbursement Model (Fee-for-Service, Capitation, Bundled Payments), By Provider Type (Hospitals, Clinics, Home Healthcare) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Medical Devices Reimbursement Market Infographic
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Market Analysis

In-depth Analysis of Medical Devices Reimbursement Market Industry Landscape

The medical devices reimbursement market's dynamics is influenced by a broad array of factors that have a bearing on the pricing, adoption and availability of medical devices . A main factor is definitely the changes in healthcare policies and legislation landscape. Reimbursement policies, which are central to the financial survival of the medical devices industry, shape not only manufacturers' strategies but also health providers' feature. Shifts in government policies, like the adjustment of the services reimbursement rates or the introduction of new payment models, are often game-changers in the market functioning.

The other one is medical technology that is never at a stop being developed. While breakthrough medical devices keep coming, the reimbursement market is also changing to find a way to incorporate these ongoing innovations. The low cost and efficient clinical implications of this apparatus beam spotlight on its reimbursement bodies. Generally speaking, manufacturers encounter the hurdle of demonstrating the worth of their products, but at the same time, affecting the knowledge and awareness of market among users.

Competition is one more of the forces that lead to the reimbursement dynamics. The concurrence of multiple players in the medical supplies industry cultivates competition beyond innovations a new medical product and extends itself to pricing strategies as well. Firms compete for a reputable position of medicines within reimbursement mechanisms to secure an advantageous position in the market. Consequently, it is difficult to foresee how the market structure and ther dynamics could change as comparison of cost, quality and reimbursement of medication are of extreme importance.

The consequence of demographic characteristics in the market environment also plays an important role. Aging population globally propelled the desire for medical related gadgets, especially for older people management and medical care of elderly. Payment systems should keep pace with health requirements that these populations face, thus directing minimal attention to the development of niche treatments.

Similar to that, the economic environment, along with the payments for the healthcare put pressure on the market which reimburses the expenditure on medical devices. Volatility of the economy and financial restrictions can influence the methods used for reimbursement by healthcare systems , which in turn will lead to change of the market dynamics. Finding a healthy equilibrium between cost containment and novel solutions in medical sphere is a complicated issue which affects process of reimbursement market’s evolution.

The importance of the stakeholders as collaborative partners to the market dynamics should not be undermined among the healthcare providers, payers, and patients. The healthcare providers try to find reimbursement models that can support their financial profitability, however, such models should be designed in a way that does not affect the quality of the services in a negative way. On the other hand, the payers are searching for cost-effective solutions that offer value to the people. Customers, on the contrary, impact the market´s equilibrium by their wishes, unnecessary requests, as well as emphasis on patient-oriented type of care.

Author
Rahul Gotadki
Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Get In Touch

Leave a Comment

FAQs

What is the current valuation of the Medical Devices Reimbursement Market?

The market valuation was 549.79 USD Billion in 2024.

What is the projected market size for the Medical Devices Reimbursement Market by 2035?

The market is projected to reach 1950.76 USD Billion by 2035.

What is the expected CAGR for the Medical Devices Reimbursement Market from 2025 to 2035?

The expected CAGR during the forecast period is 12.2%.

Which companies are considered key players in the Medical Devices Reimbursement Market?

Key players include Medtronic, Johnson & Johnson, Abbott Laboratories, and Boston Scientific.

What are the main segments of the Medical Devices Reimbursement Market?

The main segments include Diagnostic Devices, Surgical Devices, and Therapeutic Devices.

How much revenue did Diagnostic Devices generate in 2024?

Diagnostic Devices generated approximately 109.96 USD Billion in 2024.

What is the revenue projection for Surgical Devices by 2035?

Surgical Devices are projected to generate around 590.0 USD Billion by 2035.

What are the payer types in the Medical Devices Reimbursement Market?

Payer types include Private Insurance, Public Insurance, and Out of Pocket.

What is the expected revenue from Public Insurance by 2035?

Public Insurance is expected to generate approximately 950.0 USD Billion by 2035.

Which provider types are involved in the Medical Devices Reimbursement Market?

Provider types include Hospitals, Clinics, and Home Healthcare.

Market Summary

As per Market Research Future analysis, the Medical Devices Reimbursement Market was estimated at 549.79 USD Billion in 2024. The Medical Devices Reimbursement industry is projected to grow from 616.88 USD Billion in 2025 to 1950.76 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 12.2% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The Medical Devices Reimbursement Market is evolving towards value-based care and technological integration.

  • The market is witnessing an increased focus on value-based reimbursement models, particularly in North America. Integration of digital health technologies is becoming prevalent, enhancing patient engagement and data management. Regulatory adaptations are facilitating compliance and supporting innovative medical devices in both North America and Asia-Pacific. Rising demand for advanced medical technologies and expansion of health insurance coverage are key drivers propelling growth in diagnostic and therapeutic devices.

Market Size & Forecast

2024 Market Size 549.79 (USD Billion)
2035 Market Size 1950.76 (USD Billion)
CAGR (2025 - 2035) 12.2%
Largest Regional Market Share in 2024 North America

Major Players

Medtronic (US), Johnson & Johnson (US), Abbott Laboratories (US), Boston Scientific (US), Stryker Corporation (US), B. Braun Melsungen AG (DE), Siemens Healthineers (DE), Philips Healthcare (NL), GE Healthcare (US)

Market Trends

The Medical Devices Reimbursement Market is currently experiencing a transformative phase, driven by evolving healthcare policies and technological advancements. Stakeholders, including manufacturers, healthcare providers, and payers, are increasingly focused on ensuring that innovative medical devices receive appropriate reimbursement. This focus is essential for fostering the development of new technologies that can enhance patient outcomes and streamline healthcare delivery. As regulatory frameworks adapt to accommodate these innovations, the landscape of reimbursement is likely to become more complex, necessitating a thorough understanding of the various reimbursement pathways available. Moreover, the integration of digital health solutions into traditional medical devices is reshaping reimbursement strategies. Telehealth and remote monitoring technologies are gaining traction, prompting payers to reconsider their reimbursement models. This shift suggests a potential for increased access to care, particularly for underserved populations. As the Medical Devices Reimbursement Market continues to evolve, collaboration among stakeholders will be crucial in navigating the challenges and opportunities that arise from these changes. The future landscape may see a more patient-centric approach, where reimbursement policies align closely with the value delivered by medical devices, ultimately benefiting both patients and providers.

Increased Focus on Value-Based Reimbursement

The Medical Devices Reimbursement Market is shifting towards value-based reimbursement models. This trend emphasizes the importance of patient outcomes and cost-effectiveness, encouraging manufacturers to demonstrate the clinical and economic value of their products. As healthcare systems prioritize quality over quantity, reimbursement strategies are likely to evolve, aligning financial incentives with patient health improvements.

Integration of Digital Health Technologies

The rise of digital health technologies is influencing the Medical Devices Reimbursement Market. Devices that incorporate telehealth capabilities or remote monitoring features are becoming more prevalent. Payers are beginning to recognize the potential of these technologies to enhance patient engagement and improve health outcomes, leading to new reimbursement pathways that support their adoption.

Regulatory Adaptations and Compliance

Regulatory bodies are adapting their frameworks to keep pace with innovations in the Medical Devices Reimbursement Market. This trend indicates a growing need for compliance with evolving guidelines and standards. Manufacturers must stay informed about these changes to ensure their products meet reimbursement criteria, which may vary across different regions and healthcare systems.

Medical Devices Reimbursement Market Market Drivers

Expansion of Health Insurance Coverage

The expansion of health insurance coverage is a pivotal driver in the Medical Devices Reimbursement Market. As more individuals gain access to health insurance, the demand for reimbursable medical devices is likely to increase. Recent statistics indicate that insurance coverage has expanded significantly, with millions more individuals now eligible for various medical services. This expansion facilitates greater access to necessary medical devices, which in turn drives market growth. Insurers are increasingly recognizing the value of reimbursing innovative medical devices that improve patient outcomes, thus creating a more favorable environment for manufacturers and healthcare providers alike. The interplay between insurance coverage and device reimbursement is crucial for the sustainability of the Medical Devices Reimbursement Market.

Growing Emphasis on Patient-Centric Care

The growing emphasis on patient-centric care is transforming the Medical Devices Reimbursement Market. Healthcare systems are increasingly prioritizing patient outcomes and satisfaction, which influences reimbursement policies. This shift encourages the adoption of medical devices that align with patient needs and preferences. Data suggests that patient engagement in treatment decisions leads to better health outcomes, prompting insurers to support devices that facilitate this engagement. As healthcare providers focus on delivering personalized care, the demand for reimbursable medical devices that enhance patient experience is likely to rise. This trend not only benefits patients but also drives innovation and investment within the Medical Devices Reimbursement Market.

Technological Advancements in Medical Devices

Technological advancements are reshaping the Medical Devices Reimbursement Market in profound ways. Innovations such as minimally invasive surgical techniques, telemedicine, and wearable health monitoring devices are gaining traction. These advancements not only enhance patient care but also influence reimbursement policies. For instance, the integration of artificial intelligence in diagnostic devices has shown to improve accuracy and efficiency, prompting insurers to reconsider reimbursement strategies. The market for such technologically advanced devices is expected to reach a valuation of over $500 billion by 2026, reflecting the growing recognition of their value in clinical settings. As technology continues to evolve, the Medical Devices Reimbursement Market must adapt to ensure that reimbursement frameworks align with these innovations.

Rising Demand for Advanced Medical Technologies

The Medical Devices Reimbursement Market is experiencing a notable surge in demand for advanced medical technologies. This trend is driven by an increasing prevalence of chronic diseases and an aging population, which necessitate innovative medical solutions. According to recent data, the market for advanced medical devices is projected to grow at a compound annual growth rate (CAGR) of approximately 7.5% over the next five years. As healthcare providers seek to improve patient outcomes, the reimbursement landscape is adapting to accommodate these advanced technologies. This shift not only enhances patient care but also encourages manufacturers to invest in research and development, thereby fostering a cycle of innovation within the Medical Devices Reimbursement Market.

Increased Regulatory Support for Innovative Devices

Increased regulatory support for innovative medical devices is a significant driver in the Medical Devices Reimbursement Market. Regulatory bodies are streamlining approval processes for new devices, thereby facilitating quicker market entry. This support is crucial for manufacturers looking to introduce cutting-edge technologies that can improve patient care. Recent initiatives have focused on expediting the review of devices that demonstrate substantial clinical benefits. As a result, the market is witnessing a rise in the number of innovative devices eligible for reimbursement. This regulatory environment not only encourages investment in research and development but also enhances competition within the Medical Devices Reimbursement Market, ultimately benefiting patients and healthcare providers.

Market Segment Insights

By Type: Diagnostic Devices (Largest) vs. Therapeutic Devices (Fastest-Growing)

In the Medical Devices Reimbursement Market, Diagnostic Devices hold the largest market share, reflecting their critical importance in patient care and early disease detection. These devices range from imaging technologies to laboratory tests, making them vital tools that healthcare professionals rely on to make informed decisions. Surgical Devices follow closely, catering to a broad range of procedures while also contributing significantly to market dynamics. In contrast, Therapeutic Devices, while currently smaller in market share, are rapidly gaining traction due to technological advancements and increased patient awareness.

Diagnostic Devices (Dominant) vs. Surgical Devices (Emerging)

Diagnostic Devices continue to dominate the Medical Devices Reimbursement Market due to their essential role in facilitating prompt and accurate diagnoses. They are supported by a robust framework of reimbursement policies, which encourages adoption and usage across various clinical settings. On the other hand, Surgical Devices are emerging vigorously, driven by innovations in minimally invasive surgical techniques and robotic-assisted surgeries. This shift is attracting more investment and research, positioning these devices as vital contributors to enhanced surgical outcomes. The interplay between these two segments highlights a market evolving towards integrated patient care, where diagnostics and therapeutic solutions work hand-in-hand.

By Payer Type: Private Insurance (Largest) vs. Public Insurance (Fastest-Growing)

In the Medical Devices Reimbursement Market, the payer type segment is characterized by distinct distributions among private insurance, public insurance, and out-of-pocket expenses. Private insurance holds the largest share, significantly impacting the accessibility and affordability of medical devices for patients. Public insurance, while smaller in share compared to private insurance, has been gaining ground due to wider coverage and government support, especially in regions where healthcare expenditures are increasing. Out-of-pocket expenses remain a substantial concern for patients, as they reflect the remaining cost that individuals face after insurance reimbursement, often influencing purchasing decisions negatively. Growth trends in this segment are primarily driven by the increasing prevalence of chronic diseases, leading to higher demand for advanced medical devices. The push towards value-based care has also influenced payer policies, resulting in a favorable environment for public insurance to expand rapidly. Technological advancements and the introduction of innovative medical devices further compel insurers to broaden their coverage options. Moreover, the shift towards preventive care and personalized medicine is creating new reimbursement pathways, enhancing the role of both public and private insurers in this evolving landscape.

Private Insurance (Dominant) vs. Public Insurance (Emerging)

Private insurance remains the dominant payer in the Medical Devices Reimbursement Market due to its extensive network and ability to negotiate better terms with manufacturers, which translates into a wider range of covered medical devices. This segment benefits from a substantial number of insured individuals who prefer private plans that offer quicker access to advanced medical technologies. In contrast, public insurance is emerging rapidly, driven by increasing healthcare budgets and initiatives to enhance public health coverage. While historically limited to essential medical devices, public insurance is gradually expanding its scope to include advanced technologies, fostering a culture of innovation in the medical device sector. Both segments play crucial roles, with private insurance ensuring immediate access and public insurance pushing for inclusive healthcare solutions.

By Reimbursement Model: Fee-for-Service (Largest) vs. Bundled Payments (Fastest-Growing)

In the Medical Devices Reimbursement Market, the Fee-for-Service model stands out as the largest segment, capturing a significant portion of the overall market share. This payment approach enables healthcare providers to bill separately for each service rendered, thus ensuring a direct correlation between the quantity of services provided and the reimbursement received. In contrast, the Bundled Payments model is gaining traction, representing a growing alternative that consolidates payments into a single package for multiple services, thereby refining efficiency and reducing overall costs. Growth trends highlight a shift towards value-based care, with Bundled Payments emerging as the fastest-growing reimbursement model. Healthcare systems are increasingly adopting this model due to its potential to streamline patient costs and enhance care quality. The transition from traditional Fee-for-Service to Bundled Payments is driven by rising healthcare expenditures, regulatory changes promoting cost-effectiveness, and a growing emphasis on patient outcomes. As reimbursement models evolve, healthcare stakeholders are aligned with the demands for greater accountability and efficient resource utilization.

Fee-for-Service (Dominant) vs. Bundled Payments (Emerging)

Fee-for-Service remains the dominant reimbursement model in the Medical Devices Reimbursement Market, characterized by its reliance on individual service billing which maintains traditional revenue streams for healthcare providers. This model encourages providers to deliver extensive services, although it can lead to unnecessary procedures. On the other hand, Bundled Payments are emerging as a progressive alternative, appealing to providers aiming for cost efficiency and comprehensive patient care. By consolidating payments for an entire episode of care, it incentivizes providers to enhance quality and reduce superfluous interventions. The shift toward Bundled Payments reflects the healthcare industry's transition towards models emphasizing value over volume, promoting a holistic approach to patient management.

By Provider Type: Hospitals (Largest) vs. Home Healthcare (Fastest-Growing)

In the Medical Devices Reimbursement Market, Hospitals hold the largest share, driven by their extensive infrastructure and resources. Clinics come next, benefitting from a growing preference for outpatient services. Home Healthcare, while currently smaller in scale, is gaining traction due to aging populations and the shift towards more personalized care solutions. This distribution signifies a trend towards specialized care, with emphasis placed on convenience and access across different healthcare settings.

Provider Type: Hospitals (Dominant) vs. Home Healthcare (Emerging)

Hospitals dominate the Medical Devices Reimbursement Market, accounting for a significant portion of reimbursements owing to their ability to provide comprehensive care with advanced medical technologies. They benefit from established relationships with insurance providers and a well-rounded patient base, allowing for the adoption of expensive devices and innovative treatments. In contrast, Home Healthcare is emerging as a key player, appealing to patients preferring to receive care in the comfort of their homes. This segment is characterized by the rise in telehealth solutions and portable medical devices, enabling continuous monitoring and treatment, enhancing patient satisfaction while reducing hospital admissions.

Get more detailed insights about Medical Devices Reimbursement Market Research Report—Global Forecast till 2035

Regional Insights

North America : Market Leader in Innovation

North America is the largest market for medical devices reimbursement, accounting for approximately 45% of the global market share. Key growth drivers include advanced healthcare infrastructure, high healthcare expenditure, and a strong emphasis on innovation. Regulatory catalysts, such as the FDA's streamlined approval processes, further enhance market dynamics. The U.S. remains the largest contributor, followed by Canada, which holds around 10% of the market share. The competitive landscape is characterized by the presence of major players like Medtronic, Johnson & Johnson, and Abbott Laboratories. These companies leverage advanced technologies and extensive distribution networks to maintain their market positions. The U.S. healthcare system's complexity and the increasing demand for innovative medical solutions drive competition, fostering an environment conducive to growth and investment in the medical devices sector.

Europe : Regulatory Framework Enhancements

Europe is the second-largest market for medical devices reimbursement, holding approximately 30% of the global market share. The region's growth is propelled by an aging population, increasing chronic diseases, and advancements in medical technology. Regulatory changes, particularly the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR), are expected to enhance market access and safety, driving demand for innovative solutions across member states. Leading countries in this region include Germany, France, and the UK, which collectively contribute significantly to the market. The competitive landscape features key players such as Siemens Healthineers and B. Braun Melsungen AG, who are investing in R&D to meet evolving healthcare needs. The presence of a robust healthcare system and a focus on patient-centered care further stimulate market growth, making Europe a vital hub for medical device innovation.

Asia-Pacific : Emerging Market Potential

Asia-Pacific is an emerging powerhouse in the medical devices reimbursement market, accounting for approximately 20% of the global share. The region's growth is driven by increasing healthcare investments, rising disposable incomes, and a growing awareness of advanced medical technologies. Countries like China and India are leading this growth, with significant government initiatives aimed at improving healthcare access and affordability, contributing to a favorable regulatory environment. China is the largest market in the region, followed by Japan and India, which are witnessing rapid advancements in medical technology. The competitive landscape is marked by both local and international players, including GE Healthcare and Philips Healthcare, who are expanding their presence through strategic partnerships and innovations. The increasing prevalence of chronic diseases and the demand for high-quality healthcare services are further propelling market growth in this dynamic region.

Middle East and Africa : Untapped Market Opportunities

The Middle East and Africa represent a resource-rich frontier in the medical devices reimbursement market, holding approximately 5% of the global market share. The region's growth is fueled by increasing healthcare investments, government initiatives to improve healthcare infrastructure, and a rising prevalence of chronic diseases. Countries like South Africa and the UAE are leading the market, with significant investments aimed at enhancing healthcare access and quality, creating a favorable environment for medical device reimbursement. The competitive landscape is characterized by a mix of local and international players, with companies like Siemens Healthineers and Abbott Laboratories expanding their footprint. The region's diverse healthcare needs and the push for modernization in healthcare systems present significant opportunities for growth. As governments prioritize healthcare spending, the medical devices reimbursement market is poised for substantial expansion in the coming years.

Key Players and Competitive Insights

The Medical Devices Reimbursement Market is characterized by a dynamic competitive landscape, driven by innovation, regulatory changes, and the increasing demand for advanced healthcare solutions. Key players such as Medtronic (US), Johnson & Johnson (US), and Abbott Laboratories (US) are at the forefront, each adopting distinct strategies to enhance their market positioning. Medtronic (US) focuses on technological advancements in minimally invasive procedures, while Johnson & Johnson (US) emphasizes a diversified portfolio that spans surgical devices and consumer health products. Abbott Laboratories (US) is leveraging its expertise in diagnostics and cardiovascular devices, indicating a trend towards specialization in high-demand areas. Collectively, these strategies contribute to a competitive environment that is increasingly shaped by technological innovation and regulatory compliance.
In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and enhance supply chain efficiency. This approach appears to be particularly relevant in a moderately fragmented market where regional players also exert influence. The competitive structure is evolving, with larger firms seeking to optimize their operations while smaller entities focus on niche markets. The collective influence of these key players is significant, as they navigate complex reimbursement landscapes and adapt to changing healthcare policies.
In August 2025, Medtronic (US) announced a strategic partnership with a leading telehealth provider to enhance remote patient monitoring capabilities. This move is likely to bolster Medtronic's position in the digital health space, aligning with the growing trend of integrating technology into patient care. By enhancing its telehealth offerings, Medtronic may improve patient outcomes and streamline reimbursement processes, thereby reinforcing its competitive edge.
In September 2025, Johnson & Johnson (US) unveiled a new line of surgical instruments designed to improve precision in minimally invasive surgeries. This launch not only reflects the company's commitment to innovation but also positions it to capture a larger share of the surgical device market. The introduction of these advanced instruments could potentially lead to improved surgical outcomes, which may positively influence reimbursement rates as healthcare providers seek to adopt more effective solutions.
In July 2025, Abbott Laboratories (US) expanded its cardiovascular device portfolio with the introduction of a novel stent technology. This development is significant as it addresses a critical need in the treatment of coronary artery disease. By enhancing its product offerings, Abbott is likely to strengthen its market presence and improve its negotiating power with payers, which is essential in the reimbursement landscape.
As of October 2025, the Medical Devices Reimbursement Market is witnessing trends such as digitalization, sustainability, and the integration of artificial intelligence. These trends are reshaping competitive dynamics, with companies increasingly forming strategic alliances to enhance their capabilities. The shift from price-based competition to a focus on innovation and technology is evident, as firms prioritize supply chain reliability and advanced solutions to differentiate themselves in a crowded marketplace. Looking ahead, competitive differentiation will likely hinge on the ability to innovate and adapt to evolving healthcare demands, underscoring the importance of strategic foresight in navigating this complex landscape.

Key Companies in the Medical Devices Reimbursement Market include

Industry Developments

The Medical Devices Reimbursement Market has seen notable developments recently, particularly with the increasing emphasis on value-based care, influencing reimbursement policies. Key players like Stryker, Siemens Healthineers, and Medtronic are adapting to changes in reimbursement frameworks to enhance market access. As of October 2023, Thermo Fisher Scientific announced an initiative aimed at streamlining its reimbursement processes to facilitate quicker access to innovative devices. In September 2023, Boston Scientific completed its acquisition of a key competitor, emphasizing the importance of portfolio expansion in an era of evolving reimbursement policies.

Over the past 2-3 years, Smith and Nephew navigated regulatory changes successfully, positioning themselves favorably within the Global Medical Devices Reimbursement Market landscape. The market valuation is on an upward trajectory, driven by advancements in technology and increasing demand for medical devices, further catalyzed by public health needs in the wake of the pandemic. This surge is reflected in the strategies of various companies, including Baxter International's focus on expanding their services in emerging markets, which aims to improve access to advanced medical technology through enhanced reimbursement opportunities.

Future Outlook

Medical Devices Reimbursement Market Future Outlook

The Medical Devices Reimbursement Market is projected to grow at a 12.2% CAGR from 2025 to 2035, driven by technological advancements, increasing healthcare expenditures, and evolving regulatory frameworks.

New opportunities lie in:

  • Development of AI-driven reimbursement analytics platforms.
  • Expansion of telehealth reimbursement models for remote monitoring devices.
  • Partnerships with insurers for bundled payment models in surgical procedures.

By 2035, the market is expected to be robust, reflecting substantial growth and innovation.

Market Segmentation

Medical Devices Reimbursement Market Type Outlook

  • Diagnostic Devices
  • Surgical Devices
  • Therapeutic Devices

Medical Devices Reimbursement Market Payer Type Outlook

  • Private Insurance
  • Public Insurance
  • Out of Pocket

Medical Devices Reimbursement Market Provider Type Outlook

  • Hospitals
  • Clinics
  • Home Healthcare

Medical Devices Reimbursement Market Reimbursement Model Outlook

  • Fee-for-Service
  • Capitation
  • Bundled Payments

Report Scope

MARKET SIZE 2024 549.79(USD Billion)
MARKET SIZE 2025 616.88(USD Billion)
MARKET SIZE 2035 1950.76(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 12.2% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Medtronic (US), Johnson & Johnson (US), Abbott Laboratories (US), Boston Scientific (US), Stryker Corporation (US), B. Braun Melsungen AG (DE), Siemens Healthineers (DE), Philips Healthcare (NL), GE Healthcare (US)
Segments Covered Medical Device Type, Payer Type, Reimbursement Model, Provider Type, Regional
Key Market Opportunities Integration of telehealth services enhances reimbursement pathways for innovative medical devices.
Key Market Dynamics Evolving reimbursement policies drive innovation and competition in the medical devices sector, influencing market access and pricing strategies.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What is the current valuation of the Medical Devices Reimbursement Market?

The market valuation was 549.79 USD Billion in 2024.

What is the projected market size for the Medical Devices Reimbursement Market by 2035?

The market is projected to reach 1950.76 USD Billion by 2035.

What is the expected CAGR for the Medical Devices Reimbursement Market from 2025 to 2035?

The expected CAGR during the forecast period is 12.2%.

Which companies are considered key players in the Medical Devices Reimbursement Market?

Key players include Medtronic, Johnson & Johnson, Abbott Laboratories, and Boston Scientific.

What are the main segments of the Medical Devices Reimbursement Market?

The main segments include Diagnostic Devices, Surgical Devices, and Therapeutic Devices.

How much revenue did Diagnostic Devices generate in 2024?

Diagnostic Devices generated approximately 109.96 USD Billion in 2024.

What is the revenue projection for Surgical Devices by 2035?

Surgical Devices are projected to generate around 590.0 USD Billion by 2035.

What are the payer types in the Medical Devices Reimbursement Market?

Payer types include Private Insurance, Public Insurance, and Out of Pocket.

What is the expected revenue from Public Insurance by 2035?

Public Insurance is expected to generate approximately 950.0 USD Billion by 2035.

Which provider types are involved in the Medical Devices Reimbursement Market?

Provider types include Hospitals, Clinics, and Home Healthcare.

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. EXECUTIVE SUMMARY
      1. Market Overview
      2. Key Findings
      3. Market Segmentation
      4. Competitive Landscape
      5. Challenges and Opportunities
      6. Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. MARKET INTRODUCTION
      1. Definition
      2. Scope of the study
    2. RESEARCH METHODOLOGY
      1. Overview
      2. Data Mining
      3. Secondary Research
      4. Primary Research
      5. Forecasting Model
      6. Market Size Estimation
      7. Data Triangulation
      8. Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS
    1. MARKET DYNAMICS
      1. Overview
      2. Drivers
      3. Restraints
      4. Opportunities
    2. MARKET FACTOR ANALYSIS
      1. Value chain Analysis
      2. Porter's Five Forces Analysis
      3. COVID-19 Impact Analysis
  4. SECTION IV: QUANTITATIVE ANALYSIS
    1. Medical Devices Reimbursement Market, BY Type (USD Billion)
      1. Diagnostic Devices
      2. Surgical Devices
      3. Therapeutic Devices
    2. Medical Devices Reimbursement Market, BY Payer Type (USD Billion)
      1. Private Insurance
      2. Public Insurance
      3. Out of Pocket
    3. Medical Devices Reimbursement Market, BY Reimbursement Model (USD Billion)
      1. Fee-for-Service
      2. Capitation
      3. Bundled Payments
    4. Medical Devices Reimbursement Market, BY Provider Type (USD Billion)
      1. Hospitals
      2. Clinics
      3. Home Healthcare
    5. Medical Devices Reimbursement Market, BY Region (USD Billion)
      1. North America
      2. Europe
      3. APAC
      4. South America
      5. MEA
  5. SECTION V: COMPETITIVE ANALYSIS
    1. Competitive Landscape
      1. Overview
      2. Competitive Analysis
      3. Market share Analysis
      4. Major Growth Strategy in the Healthcare
      5. Competitive Benchmarking
      6. Leading Players in Terms of Number of Developments in the Healthcare
      7. Key developments and growth strategies
      8. Major Players Financial Matrix
    2. Company Profiles
      1. Medtronic (US)
      2. Johnson & Johnson (US)
      3. Abbott Laboratories (US)
      4. Boston Scientific (US)
      5. Stryker Corporation (US)
      6. B. Braun Melsungen AG (DE)
      7. Siemens Healthineers (DE)
      8. Philips Healthcare (NL)
      9. GE Healthcare (US)
    3. Appendix
      1. References
      2. Related Reports 6 LIST OF FIGURES
    4. MARKET SYNOPSIS
    5. NORTH AMERICA MARKET ANALYSIS
    6. US MARKET ANALYSIS BY TYPE
    7. US MARKET ANALYSIS BY PAYER TYPE
    8. US MARKET ANALYSIS BY REIMBURSEMENT MODEL
    9. US MARKET ANALYSIS BY PROVIDER TYPE
    10. CANADA MARKET ANALYSIS BY TYPE
    11. CANADA MARKET ANALYSIS BY PAYER TYPE
    12. CANADA MARKET ANALYSIS BY REIMBURSEMENT MODEL
    13. CANADA MARKET ANALYSIS BY PROVIDER TYPE
    14. EUROPE MARKET ANALYSIS
    15. GERMANY MARKET ANALYSIS BY TYPE
    16. GERMANY MARKET ANALYSIS BY PAYER TYPE
    17. GERMANY MARKET ANALYSIS BY REIMBURSEMENT MODEL
    18. GERMANY MARKET ANALYSIS BY PROVIDER TYPE
    19. UK MARKET ANALYSIS BY TYPE
    20. UK MARKET ANALYSIS BY PAYER TYPE
    21. UK MARKET ANALYSIS BY REIMBURSEMENT MODEL
    22. UK MARKET ANALYSIS BY PROVIDER TYPE
    23. FRANCE MARKET ANALYSIS BY TYPE
    24. FRANCE MARKET ANALYSIS BY PAYER TYPE
    25. FRANCE MARKET ANALYSIS BY REIMBURSEMENT MODEL
    26. FRANCE MARKET ANALYSIS BY PROVIDER TYPE
    27. RUSSIA MARKET ANALYSIS BY TYPE
    28. RUSSIA MARKET ANALYSIS BY PAYER TYPE
    29. RUSSIA MARKET ANALYSIS BY REIMBURSEMENT MODEL
    30. RUSSIA MARKET ANALYSIS BY PROVIDER TYPE
    31. ITALY MARKET ANALYSIS BY TYPE
    32. ITALY MARKET ANALYSIS BY PAYER TYPE
    33. ITALY MARKET ANALYSIS BY REIMBURSEMENT MODEL
    34. ITALY MARKET ANALYSIS BY PROVIDER TYPE
    35. SPAIN MARKET ANALYSIS BY TYPE
    36. SPAIN MARKET ANALYSIS BY PAYER TYPE
    37. SPAIN MARKET ANALYSIS BY REIMBURSEMENT MODEL
    38. SPAIN MARKET ANALYSIS BY PROVIDER TYPE
    39. REST OF EUROPE MARKET ANALYSIS BY TYPE
    40. REST OF EUROPE MARKET ANALYSIS BY PAYER TYPE
    41. REST OF EUROPE MARKET ANALYSIS BY REIMBURSEMENT MODEL
    42. REST OF EUROPE MARKET ANALYSIS BY PROVIDER TYPE
    43. APAC MARKET ANALYSIS
    44. CHINA MARKET ANALYSIS BY TYPE
    45. CHINA MARKET ANALYSIS BY PAYER TYPE
    46. CHINA MARKET ANALYSIS BY REIMBURSEMENT MODEL
    47. CHINA MARKET ANALYSIS BY PROVIDER TYPE
    48. INDIA MARKET ANALYSIS BY TYPE
    49. INDIA MARKET ANALYSIS BY PAYER TYPE
    50. INDIA MARKET ANALYSIS BY REIMBURSEMENT MODEL
    51. INDIA MARKET ANALYSIS BY PROVIDER TYPE
    52. JAPAN MARKET ANALYSIS BY TYPE
    53. JAPAN MARKET ANALYSIS BY PAYER TYPE
    54. JAPAN MARKET ANALYSIS BY REIMBURSEMENT MODEL
    55. JAPAN MARKET ANALYSIS BY PROVIDER TYPE
    56. SOUTH KOREA MARKET ANALYSIS BY TYPE
    57. SOUTH KOREA MARKET ANALYSIS BY PAYER TYPE
    58. SOUTH KOREA MARKET ANALYSIS BY REIMBURSEMENT MODEL
    59. SOUTH KOREA MARKET ANALYSIS BY PROVIDER TYPE
    60. MALAYSIA MARKET ANALYSIS BY TYPE
    61. MALAYSIA MARKET ANALYSIS BY PAYER TYPE
    62. MALAYSIA MARKET ANALYSIS BY REIMBURSEMENT MODEL
    63. MALAYSIA MARKET ANALYSIS BY PROVIDER TYPE
    64. THAILAND MARKET ANALYSIS BY TYPE
    65. THAILAND MARKET ANALYSIS BY PAYER TYPE
    66. THAILAND MARKET ANALYSIS BY REIMBURSEMENT MODEL
    67. THAILAND MARKET ANALYSIS BY PROVIDER TYPE
    68. INDONESIA MARKET ANALYSIS BY TYPE
    69. INDONESIA MARKET ANALYSIS BY PAYER TYPE
    70. INDONESIA MARKET ANALYSIS BY REIMBURSEMENT MODEL
    71. INDONESIA MARKET ANALYSIS BY PROVIDER TYPE
    72. REST OF APAC MARKET ANALYSIS BY TYPE
    73. REST OF APAC MARKET ANALYSIS BY PAYER TYPE
    74. REST OF APAC MARKET ANALYSIS BY REIMBURSEMENT MODEL
    75. REST OF APAC MARKET ANALYSIS BY PROVIDER TYPE
    76. SOUTH AMERICA MARKET ANALYSIS
    77. BRAZIL MARKET ANALYSIS BY TYPE
    78. BRAZIL MARKET ANALYSIS BY PAYER TYPE
    79. BRAZIL MARKET ANALYSIS BY REIMBURSEMENT MODEL
    80. BRAZIL MARKET ANALYSIS BY PROVIDER TYPE
    81. MEXICO MARKET ANALYSIS BY TYPE
    82. MEXICO MARKET ANALYSIS BY PAYER TYPE
    83. MEXICO MARKET ANALYSIS BY REIMBURSEMENT MODEL
    84. MEXICO MARKET ANALYSIS BY PROVIDER TYPE
    85. ARGENTINA MARKET ANALYSIS BY TYPE
    86. ARGENTINA MARKET ANALYSIS BY PAYER TYPE
    87. ARGENTINA MARKET ANALYSIS BY REIMBURSEMENT MODEL
    88. ARGENTINA MARKET ANALYSIS BY PROVIDER TYPE
    89. REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE
    90. REST OF SOUTH AMERICA MARKET ANALYSIS BY PAYER TYPE
    91. REST OF SOUTH AMERICA MARKET ANALYSIS BY REIMBURSEMENT MODEL
    92. REST OF SOUTH AMERICA MARKET ANALYSIS BY PROVIDER TYPE
    93. MEA MARKET ANALYSIS
    94. GCC COUNTRIES MARKET ANALYSIS BY TYPE
    95. GCC COUNTRIES MARKET ANALYSIS BY PAYER TYPE
    96. GCC COUNTRIES MARKET ANALYSIS BY REIMBURSEMENT MODEL
    97. GCC COUNTRIES MARKET ANALYSIS BY PROVIDER TYPE
    98. SOUTH AFRICA MARKET ANALYSIS BY TYPE
    99. SOUTH AFRICA MARKET ANALYSIS BY PAYER TYPE
    100. SOUTH AFRICA MARKET ANALYSIS BY REIMBURSEMENT MODEL
    101. SOUTH AFRICA MARKET ANALYSIS BY PROVIDER TYPE
    102. REST OF MEA MARKET ANALYSIS BY TYPE
    103. REST OF MEA MARKET ANALYSIS BY PAYER TYPE
    104. REST OF MEA MARKET ANALYSIS BY REIMBURSEMENT MODEL
    105. REST OF MEA MARKET ANALYSIS BY PROVIDER TYPE
    106. KEY BUYING CRITERIA OF HEALTHCARE
    107. RESEARCH PROCESS OF MRFR
    108. DRO ANALYSIS OF HEALTHCARE
    109. DRIVERS IMPACT ANALYSIS: HEALTHCARE
    110. RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    111. SUPPLY / VALUE CHAIN: HEALTHCARE
    112. Medical Devices Reimbursement Market, BY TYPE, 2024 (% SHARE)
    113. Medical Devices Reimbursement Market, BY TYPE, 2024 TO 2035 (USD Billion)
    114. Medical Devices Reimbursement Market, BY PAYER TYPE, 2024 (% SHARE)
    115. Medical Devices Reimbursement Market, BY PAYER TYPE, 2024 TO 2035 (USD Billion)
    116. Medical Devices Reimbursement Market, BY REIMBURSEMENT MODEL, 2024 (% SHARE)
    117. Medical Devices Reimbursement Market, BY REIMBURSEMENT MODEL, 2024 TO 2035 (USD Billion)
    118. Medical Devices Reimbursement Market, BY PROVIDER TYPE, 2024 (% SHARE)
    119. Medical Devices Reimbursement Market, BY PROVIDER TYPE, 2024 TO 2035 (USD Billion)
    120. BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES
    121. LIST OF ASSUMPTIONS
    122. North America MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY PAYER TYPE, 2025-2035 (USD Billion)
      3. BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion)
      4. BY PROVIDER TYPE, 2025-2035 (USD Billion)
    123. US MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY PAYER TYPE, 2025-2035 (USD Billion)
      3. BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion)
      4. BY PROVIDER TYPE, 2025-2035 (USD Billion)
    124. Canada MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY PAYER TYPE, 2025-2035 (USD Billion)
      3. BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion)
      4. BY PROVIDER TYPE, 2025-2035 (USD Billion)
    125. Europe MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY PAYER TYPE, 2025-2035 (USD Billion)
      3. BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion)
      4. BY PROVIDER TYPE, 2025-2035 (USD Billion)
    126. Germany MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY PAYER TYPE, 2025-2035 (USD Billion)
      3. BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion)
      4. BY PROVIDER TYPE, 2025-2035 (USD Billion)
    127. UK MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY PAYER TYPE, 2025-2035 (USD Billion)
      3. BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion)
      4. BY PROVIDER TYPE, 2025-2035 (USD Billion)
    128. France MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY PAYER TYPE, 2025-2035 (USD Billion)
      3. BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion)
      4. BY PROVIDER TYPE, 2025-2035 (USD Billion)
    129. Russia MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY PAYER TYPE, 2025-2035 (USD Billion)
      3. BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion)
      4. BY PROVIDER TYPE, 2025-2035 (USD Billion)
    130. Italy MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY PAYER TYPE, 2025-2035 (USD Billion)
      3. BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion)
      4. BY PROVIDER TYPE, 2025-2035 (USD Billion)
    131. Spain MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY PAYER TYPE, 2025-2035 (USD Billion)
      3. BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion)
      4. BY PROVIDER TYPE, 2025-2035 (USD Billion)
    132. Rest of Europe MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY PAYER TYPE, 2025-2035 (USD Billion)
      3. BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion)
      4. BY PROVIDER TYPE, 2025-2035 (USD Billion)
    133. APAC MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY PAYER TYPE, 2025-2035 (USD Billion)
      3. BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion)
      4. BY PROVIDER TYPE, 2025-2035 (USD Billion)
    134. China MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY PAYER TYPE, 2025-2035 (USD Billion)
      3. BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion)
      4. BY PROVIDER TYPE, 2025-2035 (USD Billion)
    135. India MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY PAYER TYPE, 2025-2035 (USD Billion)
      3. BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion)
      4. BY PROVIDER TYPE, 2025-2035 (USD Billion)
    136. Japan MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY PAYER TYPE, 2025-2035 (USD Billion)
      3. BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion)
      4. BY PROVIDER TYPE, 2025-2035 (USD Billion)
    137. South Korea MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY PAYER TYPE, 2025-2035 (USD Billion)
      3. BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion)
      4. BY PROVIDER TYPE, 2025-2035 (USD Billion)
    138. Malaysia MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY PAYER TYPE, 2025-2035 (USD Billion)
      3. BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion)
      4. BY PROVIDER TYPE, 2025-2035 (USD Billion)
    139. Thailand MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY PAYER TYPE, 2025-2035 (USD Billion)
      3. BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion)
      4. BY PROVIDER TYPE, 2025-2035 (USD Billion)
    140. Indonesia MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY PAYER TYPE, 2025-2035 (USD Billion)
      3. BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion)
      4. BY PROVIDER TYPE, 2025-2035 (USD Billion)
    141. Rest of APAC MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY PAYER TYPE, 2025-2035 (USD Billion)
      3. BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion)
      4. BY PROVIDER TYPE, 2025-2035 (USD Billion)
    142. South America MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY PAYER TYPE, 2025-2035 (USD Billion)
      3. BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion)
      4. BY PROVIDER TYPE, 2025-2035 (USD Billion)
    143. Brazil MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY PAYER TYPE, 2025-2035 (USD Billion)
      3. BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion)
      4. BY PROVIDER TYPE, 2025-2035 (USD Billion)
    144. Mexico MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY PAYER TYPE, 2025-2035 (USD Billion)
      3. BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion)
      4. BY PROVIDER TYPE, 2025-2035 (USD Billion)
    145. Argentina MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY PAYER TYPE, 2025-2035 (USD Billion)
      3. BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion)
      4. BY PROVIDER TYPE, 2025-2035 (USD Billion)
    146. Rest of South America MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY PAYER TYPE, 2025-2035 (USD Billion)
      3. BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion)
      4. BY PROVIDER TYPE, 2025-2035 (USD Billion)
    147. MEA MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY PAYER TYPE, 2025-2035 (USD Billion)
      3. BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion)
      4. BY PROVIDER TYPE, 2025-2035 (USD Billion)
    148. GCC Countries MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY PAYER TYPE, 2025-2035 (USD Billion)
      3. BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion)
      4. BY PROVIDER TYPE, 2025-2035 (USD Billion)
    149. South Africa MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY PAYER TYPE, 2025-2035 (USD Billion)
      3. BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion)
      4. BY PROVIDER TYPE, 2025-2035 (USD Billion)
    150. Rest of MEA MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY PAYER TYPE, 2025-2035 (USD Billion)
      3. BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion)
      4. BY PROVIDER TYPE, 2025-2035 (USD Billion)
    151. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    152. ACQUISITION/PARTNERSHIP

Medical Devices Reimbursement Market Segmentation

Medical Devices Reimbursement Market By Medical Device Type (USD Billion, 2019-2035)

With Diagnostic Devices

With Surgical Devices

With Therapeutic Devices

Medical Devices Reimbursement Market By Payer Type (USD Billion, 2019-2035)

Private Insurance

Public Insurance

Out of Pocket

Medical Devices Reimbursement Market By Reimbursement Model (USD Billion, 2019-2035)

Fee-for-Service

Capitation

Bundled Payments

Medical Devices Reimbursement Market By Provider Type (USD Billion, 2019-2035)

Hospitals

Clinics

Home Healthcare

 

Medical Devices Reimbursement Market By Regional (USD Billion, 2019-2035)

North America

Europe

South America

Asia Pacific

Middle East and Africa

 

Medical Devices Reimbursement Market Regional Outlook (USD Billion, 2019-2035)

 

North America Outlook (USD Billion, 2019-2035)

Medical Devices Reimbursement Market by Medical Device Type

With Diagnostic Devices

With Surgical Devices

With Therapeutic Devices

Medical Devices Reimbursement Market by Payer Type

Private Insurance

Public Insurance

Out of Pocket

Medical Devices Reimbursement Market by Reimbursement Model Type

Fee-for-Service

Capitation

Bundled Payments

Medical Devices Reimbursement Market by Provider Type

Hospitals

Clinics

Home Healthcare

Medical Devices Reimbursement Market by Regional Type

US

Canada

US Outlook (USD Billion, 2019-2035)

Medical Devices Reimbursement Market by Medical Device Type

With Diagnostic Devices

With Surgical Devices

With Therapeutic Devices

Medical Devices Reimbursement Market by Payer Type

Private Insurance

Public Insurance

Out of Pocket

Medical Devices Reimbursement Market by Reimbursement Model Type

Fee-for-Service

Capitation

Bundled Payments

Medical Devices Reimbursement Market by Provider Type

Hospitals

Clinics

Home Healthcare

CANADA Outlook (USD Billion, 2019-2035)

Medical Devices Reimbursement Market by Medical Device Type

With Diagnostic Devices

With Surgical Devices

With Therapeutic Devices

Medical Devices Reimbursement Market by Payer Type

Private Insurance

Public Insurance

Out of Pocket

Medical Devices Reimbursement Market by Reimbursement Model Type

Fee-for-Service

Capitation

Bundled Payments

Medical Devices Reimbursement Market by Provider Type

Hospitals

Clinics

Home Healthcare

Europe Outlook (USD Billion, 2019-2035)

Medical Devices Reimbursement Market by Medical Device Type

With Diagnostic Devices

With Surgical Devices

With Therapeutic Devices

Medical Devices Reimbursement Market by Payer Type

Private Insurance

Public Insurance

Out of Pocket

Medical Devices Reimbursement Market by Reimbursement Model Type

Fee-for-Service

Capitation

Bundled Payments

Medical Devices Reimbursement Market by Provider Type

Hospitals

Clinics

Home Healthcare

Medical Devices Reimbursement Market by Regional Type

Germany

UK

France

Russia

Italy

Spain

Rest of Europe

GERMANY Outlook (USD Billion, 2019-2035)

Medical Devices Reimbursement Market by Medical Device Type

With Diagnostic Devices

With Surgical Devices

With Therapeutic Devices

Medical Devices Reimbursement Market by Payer Type

Private Insurance

Public Insurance

Out of Pocket

Medical Devices Reimbursement Market by Reimbursement Model Type

Fee-for-Service

Capitation

Bundled Payments

Medical Devices Reimbursement Market by Provider Type

Hospitals

Clinics

Home Healthcare

UK Outlook (USD Billion, 2019-2035)

Medical Devices Reimbursement Market by Medical Device Type

With Diagnostic Devices

With Surgical Devices

With Therapeutic Devices

Medical Devices Reimbursement Market by Payer Type

Private Insurance

Public Insurance

Out of Pocket

Medical Devices Reimbursement Market by Reimbursement Model Type

Fee-for-Service

Capitation

Bundled Payments

Medical Devices Reimbursement Market by Provider Type

Hospitals

Clinics

Home Healthcare

FRANCE Outlook (USD Billion, 2019-2035)

Medical Devices Reimbursement Market by Medical Device Type

With Diagnostic Devices

With Surgical Devices

With Therapeutic Devices

Medical Devices Reimbursement Market by Payer Type

Private Insurance

Public Insurance

Out of Pocket

Medical Devices Reimbursement Market by Reimbursement Model Type

Fee-for-Service

Capitation

Bundled Payments

Medical Devices Reimbursement Market by Provider Type

Hospitals

Clinics

Home Healthcare

RUSSIA Outlook (USD Billion, 2019-2035)

Medical Devices Reimbursement Market by Medical Device Type

With Diagnostic Devices

With Surgical Devices

With Therapeutic Devices

Medical Devices Reimbursement Market by Payer Type

Private Insurance

Public Insurance

Out of Pocket

Medical Devices Reimbursement Market by Reimbursement Model Type

Fee-for-Service

Capitation

Bundled Payments

Medical Devices Reimbursement Market by Provider Type

Hospitals

Clinics

Home Healthcare

ITALY Outlook (USD Billion, 2019-2035)

Medical Devices Reimbursement Market by Medical Device Type

With Diagnostic Devices

With Surgical Devices

With Therapeutic Devices

Medical Devices Reimbursement Market by Payer Type

Private Insurance

Public Insurance

Out of Pocket

Medical Devices Reimbursement Market by Reimbursement Model Type

Fee-for-Service

Capitation

Bundled Payments

Medical Devices Reimbursement Market by Provider Type

Hospitals

Clinics

Home Healthcare

SPAIN Outlook (USD Billion, 2019-2035)

Medical Devices Reimbursement Market by Medical Device Type

With Diagnostic Devices

With Surgical Devices

With Therapeutic Devices

Medical Devices Reimbursement Market by Payer Type

Private Insurance

Public Insurance

Out of Pocket

Medical Devices Reimbursement Market by Reimbursement Model Type

Fee-for-Service

Capitation

Bundled Payments

Medical Devices Reimbursement Market by Provider Type

Hospitals

Clinics

Home Healthcare

REST OF EUROPE Outlook (USD Billion, 2019-2035)

Medical Devices Reimbursement Market by Medical Device Type

With Diagnostic Devices

With Surgical Devices

With Therapeutic Devices

Medical Devices Reimbursement Market by Payer Type

Private Insurance

Public Insurance

Out of Pocket

Medical Devices Reimbursement Market by Reimbursement Model Type

Fee-for-Service

Capitation

Bundled Payments

Medical Devices Reimbursement Market by Provider Type

Hospitals

Clinics

Home Healthcare

APAC Outlook (USD Billion, 2019-2035)

Medical Devices Reimbursement Market by Medical Device Type

With Diagnostic Devices

With Surgical Devices

With Therapeutic Devices

Medical Devices Reimbursement Market by Payer Type

Private Insurance

Public Insurance

Out of Pocket

Medical Devices Reimbursement Market by Reimbursement Model Type

Fee-for-Service

Capitation

Bundled Payments

Medical Devices Reimbursement Market by Provider Type

Hospitals

Clinics

Home Healthcare

Medical Devices Reimbursement Market by Regional Type

China

India

Japan

South Korea

Malaysia

Thailand

Indonesia

Rest of APAC

CHINA Outlook (USD Billion, 2019-2035)

Medical Devices Reimbursement Market by Medical Device Type

With Diagnostic Devices

With Surgical Devices

With Therapeutic Devices

Medical Devices Reimbursement Market by Payer Type

Private Insurance

Public Insurance

Out of Pocket

Medical Devices Reimbursement Market by Reimbursement Model Type

Fee-for-Service

Capitation

Bundled Payments

Medical Devices Reimbursement Market by Provider Type

Hospitals

Clinics

Home Healthcare

INDIA Outlook (USD Billion, 2019-2035)

Medical Devices Reimbursement Market by Medical Device Type

With Diagnostic Devices

With Surgical Devices

With Therapeutic Devices

Medical Devices Reimbursement Market by Payer Type

Private Insurance

Public Insurance

Out of Pocket

Medical Devices Reimbursement Market by Reimbursement Model Type

Fee-for-Service

Capitation

Bundled Payments

Medical Devices Reimbursement Market by Provider Type

Hospitals

Clinics

Home Healthcare

JAPAN Outlook (USD Billion, 2019-2035)

Medical Devices Reimbursement Market by Medical Device Type

With Diagnostic Devices

With Surgical Devices

With Therapeutic Devices

Medical Devices Reimbursement Market by Payer Type

Private Insurance

Public Insurance

Out of Pocket

Medical Devices Reimbursement Market by Reimbursement Model Type

Fee-for-Service

Capitation

Bundled Payments

Medical Devices Reimbursement Market by Provider Type

Hospitals

Clinics

Home Healthcare

SOUTH KOREA Outlook (USD Billion, 2019-2035)

Medical Devices Reimbursement Market by Medical Device Type

With Diagnostic Devices

With Surgical Devices

With Therapeutic Devices

Medical Devices Reimbursement Market by Payer Type

Private Insurance

Public Insurance

Out of Pocket

Medical Devices Reimbursement Market by Reimbursement Model Type

Fee-for-Service

Capitation

Bundled Payments

Medical Devices Reimbursement Market by Provider Type

Hospitals

Clinics

Home Healthcare

MALAYSIA Outlook (USD Billion, 2019-2035)

Medical Devices Reimbursement Market by Medical Device Type

With Diagnostic Devices

With Surgical Devices

With Therapeutic Devices

Medical Devices Reimbursement Market by Payer Type

Private Insurance

Public Insurance

Out of Pocket

Medical Devices Reimbursement Market by Reimbursement Model Type

Fee-for-Service

Capitation

Bundled Payments

Medical Devices Reimbursement Market by Provider Type

Hospitals

Clinics

Home Healthcare

THAILAND Outlook (USD Billion, 2019-2035)

Medical Devices Reimbursement Market by Medical Device Type

With Diagnostic Devices

With Surgical Devices

With Therapeutic Devices

Medical Devices Reimbursement Market by Payer Type

Private Insurance

Public Insurance

Out of Pocket

Medical Devices Reimbursement Market by Reimbursement Model Type

Fee-for-Service

Capitation

Bundled Payments

Medical Devices Reimbursement Market by Provider Type

Hospitals

Clinics

Home Healthcare

INDONESIA Outlook (USD Billion, 2019-2035)

Medical Devices Reimbursement Market by Medical Device Type

With Diagnostic Devices

With Surgical Devices

With Therapeutic Devices

Medical Devices Reimbursement Market by Payer Type

Private Insurance

Public Insurance

Out of Pocket

Medical Devices Reimbursement Market by Reimbursement Model Type

Fee-for-Service

Capitation

Bundled Payments

Medical Devices Reimbursement Market by Provider Type

Hospitals

Clinics

Home Healthcare

REST OF APAC Outlook (USD Billion, 2019-2035)

Medical Devices Reimbursement Market by Medical Device Type

With Diagnostic Devices

With Surgical Devices

With Therapeutic Devices

Medical Devices Reimbursement Market by Payer Type

Private Insurance

Public Insurance

Out of Pocket

Medical Devices Reimbursement Market by Reimbursement Model Type

Fee-for-Service

Capitation

Bundled Payments

Medical Devices Reimbursement Market by Provider Type

Hospitals

Clinics

Home Healthcare

South America Outlook (USD Billion, 2019-2035)

Medical Devices Reimbursement Market by Medical Device Type

With Diagnostic Devices

With Surgical Devices

With Therapeutic Devices

Medical Devices Reimbursement Market by Payer Type

Private Insurance

Public Insurance

Out of Pocket

Medical Devices Reimbursement Market by Reimbursement Model Type

Fee-for-Service

Capitation

Bundled Payments

Medical Devices Reimbursement Market by Provider Type

Hospitals

Clinics

Home Healthcare

Medical Devices Reimbursement Market by Regional Type

Brazil

Mexico

Argentina

Rest of South America

BRAZIL Outlook (USD Billion, 2019-2035)

Medical Devices Reimbursement Market by Medical Device Type

With Diagnostic Devices

With Surgical Devices

With Therapeutic Devices

Medical Devices Reimbursement Market by Payer Type

Private Insurance

Public Insurance

Out of Pocket

Medical Devices Reimbursement Market by Reimbursement Model Type

Fee-for-Service

Capitation

Bundled Payments

Medical Devices Reimbursement Market by Provider Type

Hospitals

Clinics

Home Healthcare

MEXICO Outlook (USD Billion, 2019-2035)

Medical Devices Reimbursement Market by Medical Device Type

With Diagnostic Devices

With Surgical Devices

With Therapeutic Devices

Medical Devices Reimbursement Market by Payer Type

Private Insurance

Public Insurance

Out of Pocket

Medical Devices Reimbursement Market by Reimbursement Model Type

Fee-for-Service

Capitation

Bundled Payments

Medical Devices Reimbursement Market by Provider Type

Hospitals

Clinics

Home Healthcare

ARGENTINA Outlook (USD Billion, 2019-2035)

Medical Devices Reimbursement Market by Medical Device Type

With Diagnostic Devices

With Surgical Devices

With Therapeutic Devices

Medical Devices Reimbursement Market by Payer Type

Private Insurance

Public Insurance

Out of Pocket

Medical Devices Reimbursement Market by Reimbursement Model Type

Fee-for-Service

Capitation

Bundled Payments

Medical Devices Reimbursement Market by Provider Type

Hospitals

Clinics

Home Healthcare

REST OF SOUTH AMERICA Outlook (USD Billion, 2019-2035)

Medical Devices Reimbursement Market by Medical Device Type

With Diagnostic Devices

With Surgical Devices

With Therapeutic Devices

Medical Devices Reimbursement Market by Payer Type

Private Insurance

Public Insurance

Out of Pocket

Medical Devices Reimbursement Market by Reimbursement Model Type

Fee-for-Service

Capitation

Bundled Payments

Medical Devices Reimbursement Market by Provider Type

Hospitals

Clinics

Home Healthcare

MEA Outlook (USD Billion, 2019-2035)

Medical Devices Reimbursement Market by Medical Device Type

With Diagnostic Devices

With Surgical Devices

With Therapeutic Devices

Medical Devices Reimbursement Market by Payer Type

Private Insurance

Public Insurance

Out of Pocket

Medical Devices Reimbursement Market by Reimbursement Model Type

Fee-for-Service

Capitation

Bundled Payments

Medical Devices Reimbursement Market by Provider Type

Hospitals

Clinics

Home Healthcare

Medical Devices Reimbursement Market by Regional Type

GCC Countries

South Africa

Rest of MEA

GCC COUNTRIES Outlook (USD Billion, 2019-2035)

Medical Devices Reimbursement Market by Medical Device Type

With Diagnostic Devices

With Surgical Devices

With Therapeutic Devices

Medical Devices Reimbursement Market by Payer Type

Private Insurance

Public Insurance

Out of Pocket

Medical Devices Reimbursement Market by Reimbursement Model Type

Fee-for-Service

Capitation

Bundled Payments

Medical Devices Reimbursement Market by Provider Type

Hospitals

Clinics

Home Healthcare

SOUTH AFRICA Outlook (USD Billion, 2019-2035)

Medical Devices Reimbursement Market by Medical Device Type

With Diagnostic Devices

With Surgical Devices

With Therapeutic Devices

Medical Devices Reimbursement Market by Payer Type

Private Insurance

Public Insurance

Out of Pocket

Medical Devices Reimbursement Market by Reimbursement Model Type

Fee-for-Service

Capitation

Bundled Payments

Medical Devices Reimbursement Market by Provider Type

Hospitals

Clinics

Home Healthcare

REST OF MEA Outlook (USD Billion, 2019-2035)

Medical Devices Reimbursement Market by Medical Device Type

With Diagnostic Devices

With Surgical Devices

With Therapeutic Devices

Medical Devices Reimbursement Market by Payer Type

Private Insurance

Public Insurance

Out of Pocket

Medical Devices Reimbursement Market by Reimbursement Model Type

Fee-for-Service

Capitation

Bundled Payments

Medical Devices Reimbursement Market by Provider Type

Hospitals

Clinics

Home Healthcare

Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

Customer Stories
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓